Lallemand inaugurates its newest division - Lallemand Health Solutions
Montreal, Canada... Lallemand Inc is pleased to announce the birth of its new division Lallemand Health Solutions.
Montreal, Canada... Lallemand Inc is pleased to announce the birth of its new division ‘’Lallemand Health Solutions’’. This new entity consolidates the internationally recognized probiotic manufacturers Institut Rosell and Harmonium International. Collectively they possess close to a century of probiotic expertise in the selection, development, production and marketing of probiotic strains, and formulations that support human health and well-being.
Lallemand Health Solutions will be dedicated in bringing to its customers, which span from the food supplement to the pharmaceutical industries, the highest quality probiotic solutions produced within current GMP and ISO 9001 environments. Thanks to its fully integrated offer ‘’Lallemand Health Solutions’’ is a unique probiotic player in the global arena that can provide its customers and partners solutions from fermentation and lyophilization all the way to finished product capabilities; a true one stop shop probiotic solutions provider.
The new division, headquartered in Montreal, Canada, is managed by Mrs. Francine Mondou, former co-founder and president of Harmonium International and is covering more than 30 countries across 5 continents ready to service your probiotic needs.
‘’Lallemand Health Solutions’’ recognized also as ‘’LHS’’, offers a full line of ready-to-market probiotic formula’s such as ; LACIDOFIL®, PROBIO’KID®, PRIOBIO’STICK®, PROTECFLOR® , can also design, develop and produce custom formulations based on the documented ROSELL®, LAFTI® or HARMONIUM® strains. Such formulations can also include premium vitamin and mineral yeasts or β-Glucans, developed and produced by the Lallemand group under the LALMIN® brand. All formulations can be delivered in bulk powder or finished product formats such as: capsules, tablets, sachets, sticks, and bottles.
Available ready-to-market probiotic blends targeting specific health segments:
• Gastrointestinal health: IBS, AAD, travelers diarrhea, …
• Immunity: kids and adults
• Women healthcare: UTI, Candidiasis, …
• Stress and anxiety
From the lab to shelf, ‘’Lallemand Health Solutions’’ controls the overall manufacturing process of its products. Our probiotic strains and formulas are produced in-house in one of our many bacteria and yeast production facilities available at the Lallemand Group to ensure customers are receiving the highest quality standard of probiotic formulations.
Institut Rosell Inc. was founded by microbiologists Dr Rosell and Dr Edouard Brochu in 1934 in Montreal and stands as a pioneer of probiotics development in North America. The Institut was acquired by the Lallemand group in 1998. Since then, with intensive research programs and a solid international partnership network with renowned research institutes, hospitals and universities, the company has always pursued its founder’s mission to document and demonstrate the benefits of probiotics on health and well-being.
Harmonium International Inc. was created in 1998 in Montreal and incorporated into Lallemand in 2011. Harmonium International's mission remains simple to this day; apply our know-how into producing unmatched quality probiotic micro-organisms, add a good portion of great customer service, personally educate and train our business partners on the health benefits of good bacteria, and formulate the best probiotic complexes to meet our clients’ needs. These longstanding ingredients have become the formula for Harmonium’s success, credibility and a reference to high quality probiotics.
Related News
-
News CPHI Podcast Series: the power of digital marketing in pharma
Digital marketing is a valuable tool for many industries, and the pharmaceutical and healthcare industry is no exception. The CPHI Podcast Series covers how marketing can be used by companies to increase their engagement and overcome challenges.&n... -
News Novel approach to creating sustainable packaging from rice husks
Researchers have created a new approach to the designing of eco-friendly nanofibres extracted from rice husks, addressing the critical need for sustainable packaging materials in food and biopharmaceutical products. -
News BioNTech to begin mRNA vaccine manufacturing in Rwanda by 2025
German biotechnology company BioNTech has stated their intentions to begin production at their mRNA vaccine factory in Rwanda by 2025, which will mark the first foreign mRNA vaccine manufacturing site on the continent of Africa. -
News Identifying Alzheimer’s Disease biomarker proteins with whole blood tests
A University of Manchester spin-out pharmaceutical company, PharmaKure, has reported successful study results for the quantification of Alzheimer’s Disease biomarker proteins with a whole blood test. -
News Bill & Melinda Gates Foundation to boost mRNA vaccine initiatives in Africa with USD $40m
To address vaccine inequality and accessibility issues, the Bill & Melinda Gates Foundation aims to deliver USD $40m to various biotech companies and vaccine manufacturers in support of mRNA vaccine development. -
News CPHI Podcast Series: Exploring neurological frontiers in Alzheimer's and beyond
The next episode of the CPHI Podcast Series delves into the science and background behind some recent developments in the field of Alzheimer's disease and neurological disorders. -
News Is patient centricity the future of pharmaceutical manufacturing?
In this interview with Sandra Sánchez y Oldenhage, President of PharmAdvice, she speaks to the importance of considering patients in the manufacturing stages of the pharmaceutical supply chain, and how it can redefine healthcare. -
News CPHI Podcast Series: How to leverage AI for Drug Discovery
Artificial intelligence is the topic of debate in the latest episode from the CPHI Podcast Series, where Digital Editor Lucy Chard speaks with Bill Whitford of DPS Group about the integration of AI in healthcare.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance